Boxer Capital

Boxer Capital accounts for 21 tracked companies with verified cap-table data, 21 of which disclose round sizes totalling $5.1B. The median disclosed raise is $205M, and the largest is Point Biopharma at $650M, ahead of Mirador Therapeutics ($650M) and Spyre Therapeutics ($644M).

The names that recur most often on these co-invested cap tables are Boxer Capital (21 companies), RA Capital Management (8 companies), Invus (6 companies), Janus Henderson Investors (6 companies), Logos Capital (5 companies), Nextech Invest (5 companies). By latest disclosed round, the market skews Series C (8), Series B (4), Series D (3), Series A (3).

• Companies tracked: 21
• Disclosed funding total: $5.1B across 21 companies
• Median disclosed raise: $205M
• Largest raise: Point Biopharma — $650M
• Stage mix: Series C 8 · Series B 4 · Series D 3 · Series A 3
• Most recent dated round: 2026-06-30

Best funded Boxer Capital companies

1. Point Biopharma — $650M (latest: IPO)
2. Mirador Therapeutics — $650M (latest: Series B)
3. Spyre Therapeutics — $644M (latest: Growth)
4. Flare Therapeutics — $287M (latest: Series C)
5. Encoded Therapeutics — $240M (latest: Series D)
6. Alterome Therapeutics — $231M (latest: Series A)
7. Enliven Therapeutics — $230M (latest: Growth)
8. Semisic — $222M (latest: Series B)
9. Asher Bio — $215M (latest: Series C)
10. Silverback Therapeutics — $210M (latest: Series C)
11. ITeos Therapeutics — $205M (latest: Series B)
12. Connect Biopharmaceuticals — $195M (latest: Series C)
13. Kinnate Biopharma — $195M (latest: Series C)
14. Black Diamond Therapeutics — $194M (latest: Series C)
15. Shoreline Biosciences — $183M (latest: Series B)

Boxer Capital — related firms and companies (56)

• Point Biopharma
• Mirador Therapeutics
• Spyre Therapeutics
• Flare Therapeutics
• Encoded Therapeutics
• Alterome Therapeutics
• Enliven Therapeutics
• Semisic
• Investors like GSR Ventures
• Investors like Meritech Capital Partners
• Investors like SV Angel
• Mersana Therapeutics
• Investors like Wellington Management
• Investors like Accel
• ITeos Therapeutics
• Investors like Liquid 2 Ventures
• Investors like Thirdbase Capital
• Investors like F-Prime
• Ceptur Therapeutics
• Investors like Altos Ventures
• Investors like Great Oaks Venture Capital
• Connect Biopharmaceuticals
• Investors like Recursive Ventures
• Investors like Accomplice
• Investors like Correlation Ventures
• BioAtla
• Investors like Lux Capital
• Investors like CRV
• Kinnate Biopharma
• Investors like Venrock
• Investors like Redpoint
• Investors like QED Investors
• Lusaris Therapeutics
• Investors like Bessemer Venture Partners
• Investors like N47
• Black Diamond Therapeutics
• Investors like Bienville Capital
• Investors like Next47
• Investors like Madrona
• Boxer Capital portfolio companies 2026
• Investors like Point72 Ventures
• Investors like Headline
• Shoreline Biosciences
• Investors like Crossbeam Venture Partners
• Investors like Upfront Ventures
• Investors like Balderton Capital
• Investors like Boxer Capital
• Investors like Gaingels
• Investors like Expansion Venture Capital
• Ajax Therapeutics
• Investors like Felicis
• Investors like Sofinnova Investments
• Asher Bio
• Companies backed by Boxer Capital
• Investors like HSG
• Investors like Service Provider Capital

Boxer Capital alternatives · All research reports